Transforming Growth Factor- beta mRNA and Protein in Hypertrophic Scar Tissues and Fibroblasts: Antagonism by IFN- alpha and IFN- gamma In Vitro and In Vivo
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Hypertrophic scarring (HSc) following burn injury is a common, disfiguring, and functionally limiting form of dermal fibrosis, compromising recovery. Previously, elevated levels of transforming growth factor-beta1 (TGF-beta1), a fibrogenic cytokine, were found in wounds and serum of severely injured patients, antagonized in part by treatment with systemic interferon-alpha2b (IFN-alpha2b) both in vitro and in vivo. It is hypothesized that in wound healing after injury, platelets are an initial source of TGF-beta, but wound fibroblasts may be capable, after activation, of autoamplification of the initial response to injury by increasing TGF-beta mRNA and protein that may subsequently be responsive to IFN therapy with IFN-alpha or IFN-gamma or both. Using three pairs of site-matched HSc and normal fibroblasts from the same individuals, nonconfluent and near confluent fibroblasts were treated with TGF-beta, and cell proliferation and collagen production were assayed using cell counting and 18O2 isotopic uptake into hydroxyproline before analysis by gas chromatography-mass spectrometry (GC-MS). HSc and normal fibroblasts were assayed for the production of TGF-beta protein secretion using ELISA for TGF-beta1, TGF-beta2, and TGF-beta3 after acidification of medium samples from 96-h cultures. HSc and normal fibroblasts were treated with IFN-alpha2b or IFN-gamma or both for 96 h. Quantitative RT-PCR and Northern analysis were performed using newly synthesized internal standards for human TGF-beta1. TGF-beta stimulates both HSc and normal fibroblast proliferation. Collagen synthesis is greater in HSc than in normal fibroblasts and is maximally stimulated at 75 pM TGF-beta. TGF-beta stimulated collagen metabolism is antagonized by IFN-alpha or IFN-gamma or both in an additive fashion. HSc and normal fibroblasts not only possess the mRNA for TGF-beta1 but also secrete mature TGF-beta protein. Treatment of HSc and normal fibroblasts with IFN-alpha2b or IFN-gamma antagonizes TGF-beta protein production, and additive effects occur. RT-PCR demonstrates that after IFN treatment, downregulation of TGF-beta1 mRNA accounts in part for the reduction in protein secretion in HSc fibroblasts. Elevations of systemic TGF-beta may be due to wound fibroblasts. TGF-beta synthesis and antagonism of fibroblast TGF-beta protein secretion occurs with either IFN-alpha or IFN-gamma, in part by downregulation of TGF-beta1 mRNA levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899 · cited 1×
“(36,37) Binding of IFN to cell surface receptors triggers a cascade of kinase-mediated signaling, leading to the activation of certain genes, resulting in growth arrest of the cells and shutdown of the synthesis of proteins, such as collagen.”
Transforming Growth Factor‐β: Major Role in Regulation of Extracellular Matrix
ROBERTS, A. B., HEINE, U. I., FLANDERS, K. C., & SPORN, M. B. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17931.x · Cited by 696
Cited by
International Clinical Recommendations on Scar Management
Mustoe, T. A., Cooter, R. D., Gold, M. H., Richard Hobbs, F. D., Ramelet, A.-A., Shakespeare, P. G., Stella, M., Téot, L., Wood, F. M., & Ziegler, U. E. (2002) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-200208000-00031 · Cited by 1,080
Topical Delivery of Silver Nanoparticles Promotes Wound Healing
Tian, J., Wong, K. K. Y., Ho, C., Lok, C., Yu, W., Che, C., Chiu, J., & Tam, P. K. H. (2007) · ChemMedChem · doi:10.1002/cmdc.200600171 · Cited by 983
MUSCLE INJURIES AND REPAIR: CURRENT TRENDS IN RESEARCH
HUARD, J., LI, Y., & FU, F. H. (2002) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200205000-00022 · Cited by 522
Syed, V. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25496 · Cited by 482
Up-to-date approach to manage keloids and hypertrophic scars: A useful guide
Arno, A. I., Gauglitz, G. G., Barret, J. P., & Jeschke, M. G. (2014) · Burns · doi:10.1016/j.burns.2014.02.011 · Cited by 365
Metadata
- Authors
- Tredget, E. E., Wang, R., Shen, Q., Scott, P. G., & Ghahary, A.
- Venue
- Journal of Interferon & Cytokine Research
- Publisher
- SAGE Publications
- Published
- 2000-02
- Volume
- 20
- Issue
- 2
- Pages
- 143-152
- ISSN
- 1079-9907 (ISSN-L)
- 1557-7465
- OpenAlex
- W2131239755
- Cited by
- 109
- References
- 2
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transforming Growth Factor- beta mRNA and Protein in Hypertrophic Scar Tissues and Fibroblasts: Antagonism by IFN- alpha and IFN- gamma In Vitro and In Vivo. https://app.cochat.ai/papers/10.1089/107999000312540
- The paper
- Tredget, E. E., Wang, R., Shen, Q., Scott, P. G., & Ghahary, A. (2000). Transforming Growth Factor- beta mRNA and Protein in Hypertrophic Scar Tissues and Fibroblasts: Antagonism by IFN- alpha and IFN- gamma In Vitro and In Vivo. Journal of Interferon & Cytokine Research. https://doi.org/10.1089/107999000312540
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.